- ホーム
- > 洋書
- > 英文書
- > Business / Economics
Full Description
The Future of Drug Discovery: Who decides which diseases to treat? provides a timely and detailed look at the efforts of the pharmaceutical industry and how they relate, or should relate, to societal needs. The authors posit that as a result of increasing risk aversion and accelerated savings in research and development, the industry is not developing drugs for increasingly prevalent diseases, such as Alzheimer's disease, untreatable pain, antibiotics and more. This book carefully exposes the gap between the medicines and therapies we need and the current business path. By analyzing the situation and discussing prospects for the next decade, the The Future of Drug Discovery is a timely book for all those who care about the development needs for drugs for disease.
Contents
00 - Introduction for the non-specialist
01 - Why there will be new drugs despite the ongoing 'crisis' of drug development in big pharma
02 - The need for medicine grows
03 - Medicines are becoming better
04 - Which diseases do we want to treat?
05 - Therapeutic Areas: strategically important diseases for the future
06 - Blockbuster proprietary drugs versus generic drugs
07 - Why is pharma a special industry?
08 - Diagnosing towards personalized medicine
09 - Personalized medicine
10 - How much can drugs cost?
11 - Modeling Drug Discovery until 2025
12 - Drug development models between 2010 and 2025
